Sun Pharma posts Rs 9.8 bn Q1 profit, beats estimates as US sales climb


India's largest drugmaker Sun Pharmaceutical Industries Ltd posted a first-quarter profit on Tuesday, beating street estimates, helped by stronger sales in the United States. Net profit came in at Rs 9.83 billion for the three months ended June 30, compared with a loss of 4.

25 billion rupees a year earlier, the company said. In the year-ago quarter, Sun Pharma incurred costs of Rs 9.51 billion related to settlements in a US antitrust case over sleep-disorder drug Modafinil. Analysts on average expected a net profit of Rs.....

This article is no longer available in our repository.

There could be multiple reasons for this.